Trial Profile
A First in Man, Phase I, Single-blind, Placebo-controlled Study Investigating the Local Tolerability, Safety and Pharmacokinetics in Three Doses of PXL01 and Placebo in 15 Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 May 2014
Price :
$35
*
At a glance
- Drugs Ensereptide (Primary)
- Indications Post-surgical adhesions
- Focus Adverse reactions
- Sponsors PharmaSurgics
- 06 May 2014 New trial record